| Drug Name: | rosaramicin (35834-26-5) |
|---|---|
| PubChem ID: | 101593043 |
| SMILES: | CCC1[C@H]([C@H]2[C@@](O2)(/C=CC(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)CC=O)C)C)C |
| InchiKey: | IUPCWCLVECYZRV-ZAVYJPKZSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 581.747 |
| LogP | : | 2.6704 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 10 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 135.13 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Adverse Gastrointestinal Effects | Alanine aminotransferase (P24298) | Adverse gastrointestinal effects [ ADR Type 1 ] | Comparison of rosaramicin and erythromycin stearate for treatment of cervical infection with Chlamydia trachomatis |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|